XDH and cardiac hypertrophy: Recent data from our lab showed that the XO inhibitor, allopurinol, is not able to attenuate T4-induced cardiac hypertrophy, cardiac dysfunction, or hemodynamic changes [56], which may signify that XO is not involved in TH-induced cardiovascular changes.